Medical Developments International Ltd (ASX:MVP) is a small but well established and profitable biotech company. Its main product is Penthrox, a fast onset, non-opioid analgesic indicated for pain relief, self-administered via an inhaler by conscious patients with trauma and those requiring analgesia for surgical procedures. It is much superior to rival products such as Panadol 4 or … Read more
To access this post, you must purchase a membership.